Partnership to fast-track MERS vaccine
Drug Discovery World
JANUARY 8, 2024
UK-based Barinthus Biotherapeutics, the Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Oxford are working together to fast-track the development of a vaccine candidate for the prevention of Middle East Respiratory Syndrome (MERS).
Let's personalize your content